Castlight Health Inc. (NYSE:CSLT) CRO John Mccracken sold 46,008 shares of Castlight Health stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $5.01, for a total transaction of $230,500.08. Following the completion of the sale, the executive now directly owns 67,591 shares of the company’s stock, valued at approximately $338,630.91. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

John Mccracken also recently made the following trade(s):

  • On Friday, November 18th, John Mccracken sold 5,570 shares of Castlight Health stock. The shares were sold at an average price of $4.81, for a total transaction of $26,791.70.
  • On Monday, November 14th, John Mccracken sold 31,780 shares of Castlight Health stock. The shares were sold at an average price of $5.00, for a total transaction of $158,900.00.
  • On Wednesday, November 16th, John Mccracken sold 99,371 shares of Castlight Health stock. The shares were sold at an average price of $5.02, for a total transaction of $498,842.42.
  • On Thursday, August 18th, John Mccracken sold 5,594 shares of Castlight Health stock. The shares were sold at an average price of $4.13, for a total transaction of $23,103.22.

Shares of Castlight Health Inc. (NYSE:CSLT) opened at 4.75 on Monday. The company has a 50-day moving average of $4.27 and a 200-day moving average of $4.13. The company’s market cap is $492.59 million. Castlight Health Inc. has a 1-year low of $2.54 and a 1-year high of $5.15.

Castlight Health (NYSE:CSLT) last released its earnings results on Wednesday, November 2nd. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. The business earned $25.50 million during the quarter, compared to the consensus estimate of $24.81 million. Castlight Health had a negative net margin of 73.57% and a negative return on equity of 58.57%. The firm’s revenue for the quarter was up 30.8% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.17) earnings per share. Equities analysts forecast that Castlight Health Inc. will post ($0.34) EPS for the current year.

Insider Buying and Selling by Quarter for Castlight Health (NYSE:CSLT)

CSLT has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Castlight Health from a “hold” rating to a “buy” rating and set a $4.25 target price for the company in a research report on Tuesday, November 8th. Canaccord Genuity reissued a “hold” rating and set a $5.00 target price on shares of Castlight Health in a research report on Thursday, August 11th. FBR & Co restated a “hold” rating and set a $4.00 price objective on shares of Castlight Health in a report on Wednesday, August 10th. Finally, Morgan Stanley restated a “hold” rating and set a $4.00 price objective on shares of Castlight Health in a report on Thursday, August 25th. Six investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Castlight Health presently has an average rating of “Hold” and an average price target of $4.58.

A number of hedge funds have recently made changes to their positions in CSLT. Bank of Montreal Can boosted its stake in shares of Castlight Health by 4,752.0% in the third quarter. Bank of Montreal Can now owns 24,260 shares of the company’s stock worth $101,000 after buying an additional 23,760 shares in the last quarter. The Manufacturers Life Insurance Company purchased a new stake in shares of Castlight Health during the third quarter worth approximately $132,000. Rhumbline Advisers boosted its stake in shares of Castlight Health by 2.1% in the third quarter. Rhumbline Advisers now owns 32,087 shares of the company’s stock worth $133,000 after buying an additional 650 shares in the last quarter. Metropolitan Life Insurance Co. NY purchased a new stake in shares of Castlight Health during the second quarter worth approximately $136,000. Finally, Stifel Financial Corp boosted its stake in shares of Castlight Health by 40.9% in the second quarter. Stifel Financial Corp now owns 38,330 shares of the company’s stock worth $152,000 after buying an additional 11,130 shares in the last quarter. Hedge funds and other institutional investors own 50.75% of the company’s stock.

Castlight Health Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families.

5 Day Chart for NYSE:CSLT

Receive News & Stock Ratings for Castlight Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health Inc. and related stocks with our FREE daily email newsletter.